1. Institute for Experimental and Clinical Pharmacology and Toxicology, Center of Brain, Behavior and Metabolism (CBBM), University of Lübeck, Lübeck, Germany.
2. ENS de Lyon, INRAE, CNRS, Institut de Génomique Fonctionnelle de Lyon, University of Lyon, Lyon, France.
3. Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S 1172, European Genomic Institute for Diabetes (EGID), University of Lille, Lille, France.
4. DZHK (German Research Centre for Cardiovascular Research), Hamburg-Lübeck-Kiel, Lübeck, Germany.